BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Deals

  Bone Biotech PolyPid Ltd. Files For A $24 Million IPO

  October 16, 2014

   · 

  1 min read
• Deals

  ConvaTec Owners Appoint Banks To Explore Sale

  October 16, 2014

   · 

  1 min read
• Business

  AstraZeneca PLC Strengthens Partnership With The University of Cambridge

  October 16, 2014

   · 

  6 min read
• Pharm Country

  Immunotherapy Study Funded By The The Leukemia & Lymphoma Society Demonstrates Remarkable Results In Patients With Acute Lymphoblastic Leukemia

  October 16, 2014

   · 

  3 min read
• Drug Development

  Cellular Biomedicine Group Launches Pre-Clinical Research Study For Chronic Obstructive Pulmonary Disease (COPD)

  October 16, 2014

   · 

  3 min read
• Drug Development

  Basilea Pharmaceutica Reports Protocol Amendment Resulting In Earlier Completion Of Isavuconazole Phase 3 Invasive Candidiasis Study

  October 16, 2014

   · 

  4 min read
• Policy

  Hunter Technology Licensed By CA Food And Drug Branch To Manufacture Finished Medical Devices For Oems; EMS Adheres To Stringent Quality Standards On Path To FDA Registration

  October 16, 2014

   · 

  2 min read
• Business

  Alphatec Spine To Release Third Quarter 2014 Financial Results

  October 16, 2014

   · 

  1 min read
• Drug Development

  Nanobiotix Receives First Approval To Start Phase 2/3 Registration Trial In Soft Tissue Sarcoma In Europe

  October 16, 2014

   · 

  8 min read
• Business

  OncoGenex Pharmaceuticals Inc. To Report Financial Results For Third Quarter 2014 On October 30, 2014

  October 16, 2014

   · 

  1 min read